What is BioPhotas?
BioPhotas, operating under the brand Celluma, specializes in professional-grade LED light therapy devices. Leveraging NASA-researched technology, their product line addresses a spectrum of health and wellness concerns, including acne, pain relief, skin aging, body contouring, and hair growth. The company's FDA-cleared devices, which combine blue, red, and near-infrared light energy, are trusted by thousands of healthcare practitioners and consumers globally. Celluma is recognized for its innovative and award-winning solutions in the light therapy market.
How much funding has BioPhotas raised?
BioPhotas has raised a total of $2.1M across 2 funding rounds:
Private Equity
$1.8M
Debt
$350K
Private Equity (2013): $1.8M, investors not publicly disclosed
Debt (2020): $350K led by PPP
Key Investors in BioPhotas
PPP
Public-Private Partnership
What's next for BioPhotas?
The recent major strategic investment signals a pivotal growth phase for BioPhotas. With substantial enterprise-level backing, the company is poised to expand its market reach and further innovate its LED light therapy technology. Future developments are likely to focus on enhancing product efficacy, exploring new therapeutic applications, and strengthening its distribution channels to cater to both professional healthcare providers and the direct-to-consumer market. This strategic financing will be instrumental in solidifying BioPhotas's leadership in the health and wellness technology sector.
See full BioPhotas company page
